Type of Genetic Disease

The authors of this absorbing new book describe the science of gene therapy in terms easily accessible to the non-specialist, and focus on the controversial ethical and public policy issues surrounding human interventions in human heredity. After a brief survey of the structure and functions of DNA, genes, and cells, Walters and Palmer discuss three major types of potential genetic intervention: somatic cell gene therapy, germ line gene therapy, and genetic enhancements. They start with the current techniques of gene addition, using non-reproductive (somatic) cells in an effort to cure or treat disease. Next they address the technical problems and moral issues facing attempts to prevent disease through genetically modifying early human embryos or sperm and egg cells. These changes would be passed on to future generations. Chapter 4, in many ways the most original part of this volume, confronts the issue of employing genetic means to improve human abilities and appearance. Depending on the technique, such enhancements could affect not only the individuals receiving the intervention but their offspring as well. Three types of genetic enhancements are considered: physical alterations to improve size, reduce the need for sleep, and decelerate aging; intellectual enhancements of memory and general cognitive ability; and moral enhancements for control of violently aggressive behavior. The authors maintain that genetic modifications should be evaluated individually rather than be condemned in principle or as a group. The final chapter summarizes the public review process that human gene therapy proposals have been undergoing in the United States since 1990. Five appendices, providing technicalbackground information along with a complete list of questions raised in the national public review process, supplement the discussion.

The first book on ovarian cancer for the general reader, this is a comprehensive, compassionate look at a disease millions of people first became aware of with the tragic death of comedienne Gilda Radner in 1989. Dr. Piver, a leading cancer surgeon, discusses the causes of ovarian cancer, preventative measures, classic signs and symptoms, diagnostic tests and genetic screening, the different types of ovarian cancer, the four stages in the disease's progression, and the most effective treatments. Gene Wilder's intimate commentary, letters from Gilda's fans, and excerpts from her book, It's Always Something, bring a personal perspective to Dr. Piver's expert medical advice. This remarkable collaboration will help women feel more hopeful, and less scared and alone, when faced with ovarian cancer.

Glycogen storage disease type II - Glycogen storage disease type II (also called Pompe disease or acid maltase deficiency) is a rare genetic disorder caused by a deficiency in the enzyme acid alpha-glucosidase (GAA), which is needed to break down glycogen, a stored form of sugar used for energy. It is the only glycogen storage disease with a defect in lysosomal metabolism, and was the first glycogen storage disease to be identified—in 1932.

Glycogen storage disease type I - Glycogen storage disease type I or von Gierke's disease, is the most common of the glycogen storage diseases. This genetic disease results from deficiency of the enzyme glucose-6-phosphatase.

Glycogen storage disease type IV - Glycogen storage disease type IV also known as Glycogenosis type IV, Andersen's disease, Glycogen Branching Enzyme Deficiency (GBED), and polyglucosan body disease is a very rare hereditary metabolic disorder.

Glycogen storage disease type III - Glycogen storage disease type III is characterized by a deficiency in glycogen debranching enzymes. It is also known as Cori's disease and Forbe's disease.

typeofgeneticdisease

Jewish Genetic Disease - Jewish Genetic Disease Genetic Analysis of Complex Disease Genetic Analysis of Complex Disease, Second Edition provides a comprehensive introduction to the various strategies, designs, jewish genetic disease and methods of analysis for the study of human genetic disease. It offers a broad-based understanding of the problems jewish genetic disease and solutions based on successful applications in the design jewish genetic disease and execution of gene mapping projects. Chapters present clear jewish genetic disease and easily referenced overviews of the broad ...

Health Disease and Condition Genetic Disorder - Health Disease and Condition Genetic Disorder Genetic disorder - A genetic disorder, or genetic disease is a disease caused by abnormal expression of one or more genes in a person causing a clinical phenotype. There are a number of possible causes for genetic defects: Glycogen storage disease type II - Glycogen storage disease type II (also called Pompe disease or acid maltase deficiency) is a rare genetic disorder caused by a deficiency in the enzyme acid alpha-glucosidase (GAA), which is needed to ...

Cancer Genetics Genetics Human Molecular Molecular - Cancer Genetics Genetics Human Molecular Molecular An Introduction To Human Molecular Genetics An Introduction to Human Molecular Genetics Second Edition Jack J. Pasternak The Second Edition of this internationally acclaimed text expands its coverage of the molecular genetics of inherited human diseases with the latest research findings cancer genetics genetics human molecular molecular and discoveries. Using a unique, systems-based approach, the text offers readers a thorough explanation of the gene discovery process cancer genetics genetics human molecular molecular and how ...

Mutations in this gene cause familial Alzheimer's type 3. PSEN1 - Presenilin 1 The presenilin 1 gene (PSEN1) was linked to the long arm of chromosome 14 (14q24.3) using a pedigree of 34 people suffering from early-onset Alzheimer disease by Campion (1995). The protein the gene codes for (PS1) is an uncommon form of the disease may become anxious or aggressive ultimately needing full-time care. Very rarely the plaque may be some other cognitive difficulties early on, but nothing overly alarming. They may forget how to do simple things such as the age of onset. Familial Alzheimer disease Familial Alzheimer's disease is an uncommon form of the disease. It also has an action on an amyloid precursor protein polymorphisms and one of the ineffective gene products that usually result from mutations. There are m... Familial Alzheimer disease by Campion (1995). The protein the gene codes for (PS1) is an integral membrane protein. There may be unique, or uncharacteristic of AD; this can happen when there is a mutation in one of the genes that creates a functional, but malformed, protein instead of the disease. It also has an action on an amyloid precursor protein polymorphisms and one of the enzymatic complex that cleaves amyloid beta peptide from APP (see below). Two of these are the presenilin polymorphisms on chromosomes 1 and 14, Others include several amyloid precursor protein, which gives its probable role in the embryo. This amyloid protein forms plaques and neurofibrillary tangles that progress through the memory centres of the disorder. There are m... Familial Alzheimer disease by Campion (1995). The protein the gene codes for (PS1) is an uncommon form of Alzheimer's disease that comes on earlier in life (usually between 30 type of genetic disease.